Recent Advances in the Heterologous Expression of Biosynthetic Gene Clusters for Marine Natural Products

Mar Drugs. 2022 May 24;20(6):341. doi: 10.3390/md20060341.

Abstract

Marine natural products (MNPs) are an important source of biologically active metabolites, particularly for therapeutic agent development after terrestrial plants and nonmarine microorganisms. Sequencing technologies have revealed that the number of biosynthetic gene clusters (BGCs) in marine microorganisms and the marine environment is much higher than expected. Unfortunately, the majority of them are silent or only weakly expressed under traditional laboratory culture conditions. Furthermore, the large proportion of marine microorganisms are either uncultivable or cannot be genetically manipulated. Efficient heterologous expression systems can activate cryptic BGCs and increase target compound yield, allowing researchers to explore more unknown MNPs. When developing heterologous expression of MNPs, it is critical to consider heterologous host selection as well as genetic manipulations for BGCs. In this review, we summarize current progress on the heterologous expression of MNPs as a reference for future research.

Keywords: biosynthetic gene clusters; genetic manipulation; heterologous expression; heterologous hosts; marine natural products.

Publication types

  • Review

MeSH terms

  • Biological Products* / metabolism
  • Biosynthetic Pathways / genetics
  • Multigene Family / genetics

Substances

  • Biological Products